Valganciclovir

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2012 publications

Cytomegalovirus Encephalitis and Cerebral Toxoplasmosis in an Immunocompetent Patient: A Rare Case Report.

Cytomegalovirus Encephalitis and Cerebral Toxoplasmosis in an Immunocompetent Patient: A Rare Case Report.

Journal: Acta medica Indonesiana

Published: April 14, 2026

Recurrent CMV Retinitis in a Daratumumab-Treated Multiple Myeloma Patient With Systemic Antiviral Intolerance.

Recurrent CMV Retinitis in a Daratumumab-Treated Multiple Myeloma Patient With Systemic Antiviral Intolerance.

Journal: Retinal cases & brief reports

Published: April 07, 2026

Maribavir for cytomegalovirus retinitis: A case series and review of the literature.

Maribavir for cytomegalovirus retinitis: A case series and review of the literature.

Journal: AJO international

Published: April 06, 2026

Nanocarriers for potential treatment of sensorineural hearing loss and retinitis in congenital cytomegalovirus.

Nanocarriers for potential treatment of sensorineural hearing loss and retinitis in congenital cytomegalovirus.

Journal: Nanomedicine (London, England)

Published: March 23, 2026

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia.

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia.

Journal: Journal of drugs in dermatology : JDD

Published: March 04, 2026

CYTOMEGALOVIRUS RETINITIS IN NON-HIV IMMUNOCOMPROMISED INDIVIDUALS ON TOFACITINIB FOR RHEUMATOID ARTHRITIS.

CYTOMEGALOVIRUS RETINITIS IN NON-HIV IMMUNOCOMPROMISED INDIVIDUALS ON TOFACITINIB FOR RHEUMATOID ARTHRITIS.

Journal: Retinal cases & brief reports

Published: March 04, 2026

Optimizing valganciclovir dosing strategies: a comprehensive review.

Optimizing valganciclovir dosing strategies: a comprehensive review.

Journal: Expert review of clinical pharmacology

Published: March 02, 2026

Management of cytomegalovirus in kidney transplantation in light of the new international recommendations

Management of cytomegalovirus in kidney transplantation in light of the new international recommendations

Journal: Nephrologie & therapeutique

Published: February 11, 2026

Anasarca Secondary to Cytomegalovirus Viremia in a Post-Liver Transplant Patient.

Anasarca Secondary to Cytomegalovirus Viremia in a Post-Liver Transplant Patient.

Journal: European journal of case reports in internal medicine

Published: February 07, 2026

Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review.

Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review.

Journal: Viruses

Published: February 07, 2026

Simultaneous LC-MS/MS method for the quantification of 5-flucytosine, ganciclovir, and valganciclovir to support combined prodrug-activated gene therapy.

Simultaneous LC-MS/MS method for the quantification of 5-flucytosine, ganciclovir, and valganciclovir to support combined prodrug-activated gene therapy.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: February 06, 2026

Sustainable RP-HPLC Method Development Using AQbD Approach for Simultaneous Estimation of Valganciclovir Hydrochloride and Piperine-Loaded Lipid Nanoparticles.

Sustainable RP-HPLC Method Development Using AQbD Approach for Simultaneous Estimation of Valganciclovir Hydrochloride and Piperine-Loaded Lipid Nanoparticles.

Journal: Biomedical chromatography : BMC

Published: January 25, 2026

Showing 1-12 of 2,012

Last Updated: 04/28/2026